RCC-EW

Zellname

Beschreibung

Bestell-Nr.

Einheit

Preis, Euro

RCC-EW

Humane Niere Klarzell-Karzinom Zell-Linie

300246

cryovial

375,00

RCC-EW

Humane Niere Klarzell-Karzinom Zell-Linie

330246

vital

465,00



Designation:RCC-EW (KTCTL-2)
Depositor:CLS
Organism:Homo sapiens (human)
Ethnicity:Caucasian
Age/Stage:71 years old
Gender:female
Tissue:Kidney
Morphology:epithelial
Celltype:polymorphcellular adenocarcinoma pT3a, N1, Mx/GIII
Description:Established from the kidney Adenocarcinoma pT3a, N1, Mx/GIII of a 71-years old female; HLA-A2 positive. (RCC-EW References = KTCTL-2)
Culture Medium:RPMI 1640 medium supplemented with 5.1 ml L-glutamine (200 mM) and 10% fetal bovine serum.
Freeze Medium:CM-1 (CLS · Cell Lines Service)
Sterility:Tests for mycoplasma, bacteria and fungi were negative
Biosafety Level:1
Tumorigenic:yes, in nude mice
Immunology:cytokeratine 8,18,19, vimentin, PAS positive


References:

Kampf G et al. Uptake of 169Yb complexes in normal and tumour cells: Influence of ligand metabolic cell activity and stability of cellular association. Nucl Med Biol 24(4):349-355, 1997.
Kopf-Maier P. The alkylator treosulfan shows activity towards human renal-cell carcinoma in vivo and in vitro. In Vivo 12(3): 275-288, 1998.
Frank MH and Pomer S. Interferon alpha2b differentially affects proliferation of two human renal cell carcinoma cell lines differing in the P-glycoprotein-associated multidrug-resistant phenotype. J Cancer Res Clin Oncol 125(2):117-120, 1999.
Kopf-Maier P. Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma. Anticancer Res 19(1A):493-504, 1999.
Zigeuner RE et al. Immunomagnetic cell enrichment detects more disseminated cancer cells than immunocytochemistry in vitro. J Urol 164(5):1834-1837, 2000.
Zigeuner RE et al. Isolation of circulating cancer cells from whole blood by immunomagnetic cell enrichment and unenriched immunocytochemistry in vitro. J Urol 169(2): 701-705, 2003.
Lutz NW et al. Investigation of multidrug resistance in cultured human renal cell carcinoma cells by 31P-NMR spectroscopy and treatment survival assays. MAGMA 18(3): 144-161, 2005.

 

  Change language: eng        Diese Seite drucken   Sitemap   Kontakt  


 
top